| James Jeffrey Cole Jr, MD | |
|
1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110-1003 | |
| (314) 362-5000 | |
| Not Available |
| Full Name | James Jeffrey Cole Jr |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 6 Years |
| Location | 1 Barnes Jewish Hospital Plz, Saint Louis, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063908010 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 2018017057 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Barnes-jewish St Peters Hospital | Saint peters, MO | Hospital |
| Progress West Hospital | O fallon, MO | Hospital |
| Missouri Baptist Medical Center | Town and country, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| James Cole Physiatry Llc | 3870976582 | 2 |
| Post-acute Physicians Of Missouri, Pc | 6002121126 | 14 |
| Integrated Rehab Consultants Llc | 7810184892 | 126 |
| Ssm Select Rehab St Louis Llc | 2567510449 | 130 |
| Integrated Rehab Consultants Llc | 7810184892 | 126 |
News Archive
Current US guidelines for the prescription of potent anticoagulants by surgeons who perform joint replacement operations could be doing patients more harm than good, according to Dr. Nigel Sharrock and his team from the Hospital for Special Surgery in New York.
Selcia Limited, a leading contract research organisation, today announced a drug discovery collaboration agreement with Gilead Sciences, Inc. (Foster City, California).
Digna Biotech and Biotecnol announced today that the Spanish Regulatory Medicine Agency has authorized the start of a Phase I Clinical Trial in healthy volunteers for Cardiotrophin-I.
Nepal can greatly reduce its vulnerability to climate-sensitive infectious diseases by improving its public health surveillance and prediction capabilities, says a paper due to be published April in Acta Tropica.
Imagine you are sitting in the back of a classroom, daydreaming about the weekend.
› Verified 6 days ago
| Entity Name | Integrated Rehab Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528379195 PECOS PAC ID: 7810184892 Enrollment ID: O20140617000546 |
News Archive
Current US guidelines for the prescription of potent anticoagulants by surgeons who perform joint replacement operations could be doing patients more harm than good, according to Dr. Nigel Sharrock and his team from the Hospital for Special Surgery in New York.
Selcia Limited, a leading contract research organisation, today announced a drug discovery collaboration agreement with Gilead Sciences, Inc. (Foster City, California).
Digna Biotech and Biotecnol announced today that the Spanish Regulatory Medicine Agency has authorized the start of a Phase I Clinical Trial in healthy volunteers for Cardiotrophin-I.
Nepal can greatly reduce its vulnerability to climate-sensitive infectious diseases by improving its public health surveillance and prediction capabilities, says a paper due to be published April in Acta Tropica.
Imagine you are sitting in the back of a classroom, daydreaming about the weekend.
› Verified 6 days ago
| Entity Name | Post-acute Physicians Of Missouri, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164818290 PECOS PAC ID: 6002121126 Enrollment ID: O20150819007678 |
News Archive
Current US guidelines for the prescription of potent anticoagulants by surgeons who perform joint replacement operations could be doing patients more harm than good, according to Dr. Nigel Sharrock and his team from the Hospital for Special Surgery in New York.
Selcia Limited, a leading contract research organisation, today announced a drug discovery collaboration agreement with Gilead Sciences, Inc. (Foster City, California).
Digna Biotech and Biotecnol announced today that the Spanish Regulatory Medicine Agency has authorized the start of a Phase I Clinical Trial in healthy volunteers for Cardiotrophin-I.
Nepal can greatly reduce its vulnerability to climate-sensitive infectious diseases by improving its public health surveillance and prediction capabilities, says a paper due to be published April in Acta Tropica.
Imagine you are sitting in the back of a classroom, daydreaming about the weekend.
› Verified 6 days ago
| Entity Name | James Cole Physiatry Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982336988 PECOS PAC ID: 3870976582 Enrollment ID: O20220812002228 |
News Archive
Current US guidelines for the prescription of potent anticoagulants by surgeons who perform joint replacement operations could be doing patients more harm than good, according to Dr. Nigel Sharrock and his team from the Hospital for Special Surgery in New York.
Selcia Limited, a leading contract research organisation, today announced a drug discovery collaboration agreement with Gilead Sciences, Inc. (Foster City, California).
Digna Biotech and Biotecnol announced today that the Spanish Regulatory Medicine Agency has authorized the start of a Phase I Clinical Trial in healthy volunteers for Cardiotrophin-I.
Nepal can greatly reduce its vulnerability to climate-sensitive infectious diseases by improving its public health surveillance and prediction capabilities, says a paper due to be published April in Acta Tropica.
Imagine you are sitting in the back of a classroom, daydreaming about the weekend.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Jeffrey Cole Jr, MD 600 S Euclid Ave # 8121, Saint Louis, MO 63110-1010 Ph: (314) 362-5000 | James Jeffrey Cole Jr, MD 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110-1003 Ph: (314) 362-5000 |
News Archive
Current US guidelines for the prescription of potent anticoagulants by surgeons who perform joint replacement operations could be doing patients more harm than good, according to Dr. Nigel Sharrock and his team from the Hospital for Special Surgery in New York.
Selcia Limited, a leading contract research organisation, today announced a drug discovery collaboration agreement with Gilead Sciences, Inc. (Foster City, California).
Digna Biotech and Biotecnol announced today that the Spanish Regulatory Medicine Agency has authorized the start of a Phase I Clinical Trial in healthy volunteers for Cardiotrophin-I.
Nepal can greatly reduce its vulnerability to climate-sensitive infectious diseases by improving its public health surveillance and prediction capabilities, says a paper due to be published April in Acta Tropica.
Imagine you are sitting in the back of a classroom, daydreaming about the weekend.
› Verified 6 days ago
Dr. Jai S Park, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1 Jefferson Barracks Dr, Saint Louis, MO 63125 Phone: 314-652-4100 | |
Dr. Russell C Cantrell, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1001 S. Kirkwood Road, Suite 120, Saint Louis, MO 63122 Phone: 314-966-8887 Fax: 314-966-3869 | |
Amelia Ni, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-514-3901 | |
Dr. John E Del Rosario, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 10010 Kennerly Rd, 4th Floor - Acute Rehab, Saint Louis, MO 63128 Phone: 314-525-4522 Fax: 314-525-4598 | |
Dr. Devyani Mehta Hunt, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4921 Parkview Pl, Dept Orthopaedic Surgery, Ste 6a/6b/12a, Saint Louis, MO 63110 Phone: 314-747-2551 Fax: 314-747-2598 | |
Dr. Andrea Boss Mccullough, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 4921 Parkview Pl, Dept Orthopaedic Surgery, Ste 6a/6b/12a, Saint Louis, MO 63110 Phone: 314-747-2551 Fax: 314-747-2598 |